Filter by news category
Filter by business unit / brand
1st July 2025
DIH Appoints Rehazentrum Valens as a DIH Center of Excellence
DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.
MORE
4th February 2025
DIH Expands Strategic Partnership with Zahrawi Group
DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.
MORE
4th February 2025
DIH Announces Closing of $4.6 Million Public Offering
DIH Holding US, Inc., today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit.
MORE
28th January 2025
DIH Announces Strategic Partnership with Nobis Rehabilitation Partners
DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), today announced its new partnership with Nobis Rehabilitation Partners. This collaboration signifies an important advancement as Nobis plans to integrate Andago®, an overground gait and balance training device, into every one of their newly established hospitals.
MORE
23rd December 2024
DIH Appoints Shepherd Center as a DIH Center of Excellence
DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI) today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery.
MORE
16th December 2024
DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence
DIH Holding US, Inc. (NASDAQ: DHAI) today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient recovery journeys through innovation-driven care solutions.
MORE
15th November 2024
DIH Announces Second Quarter 2025 Financial Results and Restates June 30, 2024 Form 10-Q
DIH Holding US, Inc. (NASDAQ: DHAI) announced a 39% year-over-year revenue increase in Q2 2025, reaching $18.2M, driven by 49% growth in device revenue. The EMEA region led with a 72% increase, and gross margin improved to 52.6%. Fiscal 2025 revenue guidance is updated to $60M–$67M.
MORE
5th November 2024
DIH Appoints Dietmar Dold as Chief Operating Officer
Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale.
MORE
26th September 2024
DIH Announces Formation and Inaugural Meeting of Scientific Advisory Board
The newly formed SAB will advise DIH on technical and scientific pursuits, offer insights into the latest trends in the scientific and clinical communities, provide feedback on product development, and advise DIH on research plans and projects.
MORE
30th August 2024
DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence
DIH Holding US, Inc. has named Haapsalu Neurological Rehabilitation Center in Estonia as its latest Center of Excellence. HNRC, known for its pioneering work in neurological rehabilitation, is the first in the Baltics to receive this recognition.
MORE
X
